The Government Has Shut Down... How Did We Get Here and What Does it Mean for Providers?

Published in Government Relations on October 01, 2025

As expected, Democrat and Republican members of the Senate were unable to agree on terms in passing a continuing resolution (CR) ahead of the October 1 deadline, resulting in a government shutdown. But how did we get here?  

Key Issues Behind the Stalemate 

  1. Healthcare Subsidies 
    1. Democrats demanded the extension of Affordable Care Act (ACA) subsidies, which help millions afford health insurance. These subsidies are set to expire at the end of 2025, and Democrats insisted they be included in any funding bill to prevent approximately 22 million Americans from losing coverage or seeing drastic increases in premiums.  
  2. Medicaid Cuts 
    1. Democrats also sought to reverse Medicaid cuts enacted under President Donald Trump’s summer legislation, H.R. 1, known as the “One Big Beautiful Bill Act.” Republicans refused to negotiate these issues within the context of a funding bill.  
  3. Partisan Gridlock 
    1. Republicans, who control both chambers of Congress, pushed for a “clean” CR to extend funding through November 21 without policy add-ons. Democrats blocked this, arguing that healthcare provisions were essential and time-sensitive.  
  4. Senate Rules and Power Dynamics 
    1. Although Republicans hold a majority in the Senate (53 seats), they needed 60 votes to pass most legislation. This gave Democrats leverage to block GOP proposals and push for their own priorities.  
  5. Presidential Influence 
    1. President Trump signaled a willingness to use the shutdown to permanently cut federal programs and staff, directing agencies to prepare for layoffs, not just furloughs. This escalated tensions and made compromise more difficult.  

Failed Negotiations 

  • Republican Proposal: A CR to extend funding without policy changes. 
  • Democratic Proposal: A shorter-term CR with ACA subsidy extensions and Medicaid reversals. 
  • Outcome: Both bills failed in the Senate, largely following party lines. The House adjourned without further votes, and the government shut down at midnight on October 1. 

Impact 

  • Federal Employees: Over 750,000 furloughed, with another 700,000 working without pay.  
  • Essential Services: Some services (e.g., TSA, military, Medicare) continue, but many agencies face partial or full suspensions. 
  • Economic Cost: Estimated at $400 million per day in lost compensation alone. 

What Does It Mean For Providers?  

As we said in our previous article, despite a shutdown, Medicare and Medicaid reimbursements will continue. These programs are funded through mandatory spending, meaning claims processing and payments to HME providers are not subject to annual appropriations and will proceed as usual. This ensures that providers can still receive reimbursement for covered equipment and services, such as oxygen supplies, mobility aids, and CPAP machines.  

Additionally, FDA oversight of medical devices remains active, including emergency responses to product recalls and monitoring for adverse events. This helps maintain safety and compliance standards for HME products. 

However, telehealth flexibilities expired on September 30, reverting to pre-pandemic era regulations:  

  • Home-based telehealth visits for non-behavioral health services will no longer be reimbursed.  
  • Geographic restrictions will return, limiting coverage to rural areas and approved facilities.  
  • Audio-only visits will lose coverage for most services.  
  • FQHCs and RHCs will lose distant site billing privileges.  
  • Hospital-at-Home and other waivers will end.  

No one knows how long the shutdown will last and what negotiations may include at this point. It is important to remember that during a shutdown, legislators still work and still meet with constituents. Continue to advocate for legislation and the impact our essential products and services have on patients.  

Continue to stay connected with VGM Group and industry stakeholders for resources and updates as they occur.  

From Our Experts

Advocacy in Action: Texas DME Providers Stand Up For Patient Care thumbnail Advocacy in Action: Texas DME Providers Stand Up For Patient Care Texas DME providers are speaking out against proposed Medicaid reimbursement rate cuts that threaten access to essential medical equipment for vulnerable patients. At a recent public hearing, voices from across the state shared powerful stories about the real-world impact of these cuts—some as high as 85%. The Shutdown Has Ended—Now It's Time To Take Action thumbnail The Shutdown Has Ended—Now It's Time To Take Action The recent government shutdown created uncertainty across the healthcare landscape, and the DMEPOS community was no exception. In the weeks ahead, critical decisions will shape the future of our industry. By getting involved early—through advocacy, education, and collaboration—you can help ensure these policies support patients and providers rather than hinder them. Notably, the Continuing Resolution (CR) includes an extension of Medicare telehealth flexibilities through January 2026... New Issue Brief: Why Medicare's Competitive Bidding Program Needs Urgent Reform thumbnail New Issue Brief: Why Medicare's Competitive Bidding Program Needs Urgent Reform The Medicare competitive bidding program for durable medical equipment (DME) was designed to reduce costs—but it's failing patients and providers. A new issue brief from Pacific Research Institute and economist Wayne Winegarden highlights what changes are urgently needed. Champions of Change: DME Advocates Driving Real Change thumbnail Champions of Change: DME Advocates Driving Real Change Real change starts with real people. In this edition of Champions of Change, we're spotlighting two DME advocates who aren't just talking about problems—they're taking action. David Griffin and Gary Rench are showing us what it means to stand up for patients, providers, and the future of our industry. Join HME Industry Letter on CB Program to CMS Administrator Oz thumbnail Join HME Industry Letter on CB Program to CMS Administrator Oz HME suppliers, manufacturers, and distributors are invited to add their company's name to a letter to CMS Administrator Dr. Mehmet Oz regarding the Administration's DMEPOS/Home Health Proposed Rule that includes provisions for a new competitive bidding round. The letter specifically asks CMS to withdraw or delay the DMEPOS provisions in the Proposed Rule and re-engage with industry, patient, and clinical stakeholders to design an evidence-based, fraud-resistant, America-First framework. Take Action Today: Urge CMS to Pause and Re-Evaluate the Competitive Bidding Program thumbnail Take Action Today: Urge CMS to Pause and Re-Evaluate the Competitive Bidding Program Now is the time to raise our voices. With the formal announcement of the Competitive Bidding (CB) Program expected as early as the end of this month, we must act swiftly and decisively. Below are two key opportunities to engage with your U.S. Representative and encourage their support for a Congressional letter urging Centers for Medicare & Medicaid Services (CMS) to pause and reassess the CB Program. Legislative Momentum in the HME Industry: Key Updates & Action Items thumbnail Legislative Momentum in the HME Industry: Key Updates & Action Items The past few months have seen a surge of legislative activity in the home medical equipment sector, with several key developments shaping policy and advocacy efforts across the industry. From new bills introduced in Congress to formal comment submissions and stakeholder mobilization, these events reflect growing momentum around critical issues affecting providers and patients alike. This article offers a comprehensive recap of recent actions and outlines important next steps for those... VGM Submits Comments Regarding the Section 232 National Security Investigation On Medical Imports thumbnail VGM Submits Comments Regarding the Section 232 National Security Investigation On Medical Imports VGM has submitted formal comments to the U.S. Department of Commerce in response to its Section 232 National Security Investigation into the importation of personal protective equipment (PPE), medical consumables, and medical equipment and devices.